Oracle (ORCL)
(Delayed Data from NYSE)
$116.49 USD
-0.72 (-0.61%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $116.49 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$116.49 USD
-0.72 (-0.61%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $116.49 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Zacks News
AMD Q4 Earnings In Line, Top Line Aided by Solid Client Growth
by Zacks Equity Research
AMD's fourth-quarter 2023 results reflect robust Client and Data Center revenues that offset weakness in the Gaming and Embedded segments.
Here is What to Know Beyond Why Oracle Corporation (ORCL) is a Trending Stock
by Zacks Equity Research
Oracle (ORCL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights Oracle, Progressive, MercadoLibre, Moderna and Agilent
by Zacks Equity Research
Oracle, Progressive, MercadoLibre, Moderna and Agilent are included in this Analyst Blog.
Oracle (ORCL) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Oracle (ORCL) concluded the recent trading session at $115, signifying a +0.6% move from its prior day's close.
Top Stock Reports for Oracle, Progressive & MercadoLibre
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), The Progressive Corporation (PGR) and MercadoLibre, Inc. (MELI).
Oracle (ORCL) Opens OCI Generative AI Service for Enterprises
by Zacks Equity Research
Oracle (ORCL) makes OCI Generative AI service available in order to aid businesses.
Oracle (ORCL) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
Oracle (ORCL) closed the most recent trading day at $109.67, moving +0.89% from the previous trading session.
Why Is BlackBerry (BB) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
BlackBerry (BB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Trending Stock Oracle Corporation (ORCL) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Oracle (ORCL). This makes it worthwhile to examine what the stock has in store.
Oracle Corporation (ORCL) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Oracle (ORCL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights NVIDIA, Oracle, The TJX Companies, Chubb and Xylem
by Zacks Equity Research
NVIDIA, Oracle, The TJX Companies, Chubb and Xylem are part of the Zacks top Analyst Blog .
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Top Stock Reports for NVIDIA, Oracle & The TJX Companies
by Mark Vickery
Toda's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Oracle Corporation (ORCL) and The TJX Companies, Inc. (TJX).
Oracle (ORCL) Fusion Cloud Offering Aids North Memorial Health
by Zacks Equity Research
Oracle (ORCL) Fusion Cloud Applications is adopted by North Memorial Health to unify and streamline finance, supply chain and HR processes.
Alphabet (GOOGL) Bolsters Healthcare Offerings With MedLM
by Zacks Equity Research
Alphabet's (GOOGL) Google unveils MedLM to bolster its healthcare offerings with generative AI.
Oracle (ORCL) Service Boosts East U.S. Azure Datacenters
by Zacks Equity Research
Oracle (ORCL) announces that the Oracle Database@Azure service is now generally available in the Microsoft Azure East U.S. region.
Oracle (ORCL) Makes History With Two Cloud Regions in Chile
by Zacks Equity Research
Oracle (ORCL) achieves the milestone of being the first hyperscale to establish two cloud regions in Chile.
Company News for Dec 13, 2023
by Zacks Equity Research
Companies In The Article Are: ORCL, JCI, LCID, GOOG
What's the Fed Going to Say About All This Bullishness?
by Mark Vickery
Fed Chair Powell might make quick work of the notion of early 2024 rate cuts in a mere phrase or two.
ETFs in Focus Post Oracle's Fiscal Q2 Earnings
by Sweta Killa
Oracle (ORCL) provided downbeat revenue guidance, citing strong competition in the cloud-computing industry. However, it beat earnings estimates.
Is Oracle (ORCL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Oracle (ORCL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Oracle (ORCL) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Oracle's (ORCL) fiscal second-quarter performance benefits from a steady adoption of Gen 2 Cloud, Fusion and Autonomous Database despite slow cloud revenue growth.
Markets Trade Up Ahead of CPI, Fed Meeting
by Mark Vickery
CPI numbers tomorrow are not expected to spike hotter; even if they do, one set of data points would almost assuredly not be enough for the Fed to consider making a move.
Compared to Estimates, Oracle (ORCL) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Oracle (ORCL) give a sense of how its business performed in the quarter ended November 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Oracle (ORCL) Q2 Earnings Top Estimates
by Zacks Equity Research
Oracle (ORCL) delivered earnings and revenue surprises of 1.52% and 0.84%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?